Oscillo Biosciences is a leading brand that is dedicated to the development of innovative treatments for neurodegenerative disorders. Their team is motivated by personal experiences with Alzheimer's Disease, Parkinson's, and other neurological disorders, and they envision a future where everyone affected by these conditions has access to a range of therapies that can reverse or minimize disease progression. At the heart of Oscillo Biosciences' approach is the groundbreaking science of music and brain wave stimulation.

Led by their founder and Chief Science Officer, Dr. Edward Large, a renowned music and neuroscience expert, the team has discovered that synchronized light pulses and musical stimulus can induce profound and sustained changes in the brain. By amplifying these effects, Oscillo Biosciences aims to revolutionize the treatment of neurological disorders.

With a passionate executive leadership team and scientific advisors, Oscillo Biosciences is pushing the boundaries of neuroscience and medicine. Their research and development efforts have garnered recognition, including a Phase I SBIR Grant from NIH-NIA. Through their innovative approach, Oscillo Biosciences is paving the way for a new era in the treatment of neurodegenerative diseases